538965.BO Net Margin
As of 2025-07-10, the Net Margin of Concord Drugs Ltd (538965.BO) is 0.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
538965.BO Net Margin - Historical Value
| Date | Value |
|---|---|
| 2025-03-31 | 0.7% |
| 2024-03-31 | 1.1% |
| 2023-03-31 | 1.9% |
| 2022-03-31 | 2.7% |
| 2021-03-31 | 6.4% |
| 2020-03-31 | 0.6% |
| 2019-12-31 | 0.4% |
| 2019-09-30 | 0.4% |
| 2019-06-30 | 1% |
| 2019-03-31 | 0.4% |
538965.BO Net Margin - Peers Comparison